Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$14,300,677
+$10,541,869 QoQ
Shares Held
113,192
+319.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#373
of 2,266 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EP Wealth Advisors, LLC holds $468,870,808 across 14 Drug Manufacturers - General names. GILD ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
708,767 | $180,005,554 | |
| 2 | LLY |
ELI LILLY & Co
|
96,123 | $115,292,819 | |
| 3 | ABBV |
AbbVie Inc.
|
297,328 | $74,819,617 | |
| 4 | MRK |
Merck & Co., Inc.
|
282,377 | $36,285,444 | |
| 5 | AMGN |
Amgen Inc
|
70,291 | $25,453,776 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
113,192 | $14,300,677 | |
| 7 | NVS |
Novartis AG
|
38,592 | $6,048,138 | |
| 8 | PFE |
Pfizer Inc
|
247,206 | $5,952,720 |
All Filings in GILD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,300,677 | 113,192 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,758,808 | 26,970 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,472,437 | 28,291 | Shares | Sole | 2026-02-18 | |
| 2025-06-30 | $3,243,612 | 29,256 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,090,787 | 27,584 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,706,810 | 29,304 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,523,251 | 53,951 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $3,256,161 | 47,459 | Shares | Sole | 2024-08-19 | |
| 2024-03-31 | $3,437,769 | 46,932 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,845,220 | 47,466 | Shares | Sole | 2024-02-28 | |
| 2023-09-30 | $3,530,423 | 47,110 | Shares | Sole | 2023-11-24 | |
| 2023-06-30 | $3,125,188 | 40,550 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $108 | 60,000 | Shares | Sole | 2023-06-05 | |
| 2022-12-31 | $630,053 | 7,339 | Shares | Sole | 2023-06-12 | |
| 2022-06-30 | $502,144 | 8,124 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $307,951 | 5,180 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $405,744 | 5,588 | Shares | Sole | 2022-02-17 | |
| 2021-06-30 | $340,788 | 4,949 | Shares | Sole | 2021-08-24 | |
| 2021-03-31 | $330,905 | 5,120 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $255,729 | 4,047 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $299,758 | 3,896 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $414,394 | 5,543 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||